Ind-Swift Laboratories Limited
Incorporated in 1995, Ind-Swift Laboratories Ltd is in the business of Bulk Drugs & Pharmaceuticals
What Ind-Swift files
- Others65
- Important25
- Updates24
- Board Meeting13
- Insider Trade6
- QIP/Rights/Pref.6
Ind-Swift Laboratories has launched a special window for shareholders to transfer and dematerialize physical shares. This initiative simplifies converting physical holdings into electronic form, improving ease of trading.
Ind-Swift Labs partnered with Him Infratech to build a new 40 Cr warehouse with 11000-pallet capacity in Punjab. This facility, expected within 300 days, aims to enhance storage, logistics, and operational efficiencies, benefiting overall business.
🚨 #INDSWFTLAB Update: 65 lakh fully convertible warrants, originally allotted to Saral Incorporated VCC Sub Fund 1, have lapsed. These warrants were not exercised by the February 28, 2026 deadline. **The Issue:** A non-promoter warrant holder failed to convert their warrants into equity shares within the 18-month period. **Impact:** INDSWFTLAB...
Ind-Swift Labs secured NSE approval for listing new shares from its recent merger. BSE approval is awaited but expected shortly. Upon BSE clearance, shares will be credited to investor Demat accounts, allowing trading access for shareholders.
Ind-Swift Labs' promoter group completed an internal transfer of 249,000 equity shares (0.31%) to legal heirs following a demise. This familial re-arrangement ensures the aggregate promoter shareholding remains unchanged, indicating no shift in overall control.